<?xml version="1.0" encoding="UTF-8"?>
<ref id="B62-pharmaceuticals-12-00060">
 <label>62.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dejnirattisai</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Supasa</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Wongwiwat</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Rouvinski</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Barba-Spaeth</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Duangchinda</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Sakuntabhai</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Cao-Lormeau</surname>
    <given-names>V.-M.</given-names>
   </name>
   <name>
    <surname>Malasit</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Rey</surname>
    <given-names>F.A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus</article-title>
  <source>Nat. Immunol.</source>
  <year>2016</year>
  <volume>17</volume>
  <fpage>1102</fpage>
  <lpage>1108</lpage>
  <pub-id pub-id-type="doi">10.1038/ni.3515</pub-id>
  <?supplied-pmid 27339099?>
  <pub-id pub-id-type="pmid">27339099</pub-id>
 </element-citation>
</ref>
